Status:

RECRUITING

Exploring the Recovery Function of Sleep in Neurodegeneration

Lead Sponsor:

University of Zurich

Conditions:

Neurodegenerative Diseases

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The overall objective of this study is to identify the best approach for assessing the recovery function of sleep in neurodegenerative diseases associated with abnormal protein aggregation with regard...

Detailed Description

First, the investigators want to assess the relationship between sleep parameters (e.g. sleep intensity) and behavioral/cognitive performance and subjective measures (e.g. sleep quality, mood, and sle...

Eligibility Criteria

Inclusion

  • Good general health or confirmed diagnosis of neurodegenerative disease associated with abnormal protein aggregation along international criteria
  • Age above 18 years
  • In ambulant setting: ability to apply the ambulant EEG device for the duration of the study, either alone or with help of co-habitant if MoCA \< 20

Exclusion

  • Failure to give informed consent
  • Inability to follow the procedures of the study, e.g. due to language problems or cognitive deficits
  • Known or suspected non-compliance, drug- or medication abuse
  • Inability to hear the tones to be applied during sleep in auditory stimulation experiments
  • Skin disorders/problems/allergies in face/ear area that could worsen with electrode application
  • Regular intake of drugs that may alter the relationship between sleep and outcome variables under investigation (opioids, benzodiazepines and z-drugs (nonbenzodiazepines)).
  • Clinically significant concomitant disease states
  • Too high (disease) burden for patients
  • Additional non-medical exclusion criteria may be defined for certain cognitive tasks (e.g. no glasses during experiments involving eye tracking)

Key Trial Info

Start Date :

March 14 2022

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

June 1 2026

Estimated Enrollment :

200 Patients enrolled

Trial Details

Trial ID

NCT05402488

Start Date

March 14 2022

End Date

June 1 2026

Last Update

June 2 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University Hospital Zurich, Neurology department

Zurich, Canton of Zurich, Switzerland, 8091